{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:43:08Z","timestamp":1790718188578,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13287-017-0735-7","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T01:27:47Z","timestamp":1514856467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":161,"title":["The limited application of stem cells in medicine: a review"],"prefix":"10.1186","volume":"9","author":[{"given":"Jordan","family":"Poulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"735_CR1","unstructured":"House of Lords. Stem cell research. HANSARD. 2011; Vol. 724."},{"key":"735_CR2","unstructured":"Report of the committee of inquiry into human fertilisation and embryology. London: Her Majesty's Stationery Office; 1984."},{"key":"735_CR3","unstructured":"Guidelines for stem cell research and clinical translation. 2016. International Society for Stem Cell Research (ISSCR)."},{"key":"735_CR4","unstructured":"European Commission. Article 19(3), Horizon 2020 Framework Programme Regulation (EU) No 1291\/2013"},{"key":"735_CR5","volume-title":"World stem cell policies","author":"The Hinxton Group","year":"2006","unstructured":"The Hinxton Group. World stem cell policies. Baltimore: The Johns Hopkins Berman Institute of Bioethics; 2006."},{"issue":"1","key":"735_CR6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1741-7015-9-52","volume":"9","author":"A Trounson","year":"2011","unstructured":"Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC Med. 2011;9(1):52.","journal-title":"BMC Med"},{"issue":"4","key":"735_CR7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"key":"735_CR8","unstructured":"Human and Fertilisation Embryology Act. Chapter 37 for ruling on primitive streak. Paragraph 3(4) of Schedule 2 for provisions allowing for genetic engineering of hESC. London: Her Majesty's Stationery Office; 1990."},{"issue":"4","key":"735_CR9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/030631293023004004","volume":"23","author":"M Mulkay","year":"1993","unstructured":"Mulkay M. Rhetorics of hope and fear in the great embryo debate. Soc Stud Sci. 1993;23(4):721\u201342.","journal-title":"Soc Stud Sci"},{"issue":"1","key":"735_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1467-923X.2009.01959.x","volume":"80","author":"S Kettell","year":"2009","unstructured":"Kettell S. Did secularism win out? The debate over the Human Fertilisation and Embryology Bill. Political Q. 2009;80(1):67\u201375.","journal-title":"Political Q"},{"key":"735_CR11","volume":"6","author":"J Aach","year":"2017","unstructured":"Aach J, Lunshof J, Iyer E. Church GM. Addressing the ethical issues raised by synthetic human entities with embryo-like features elife. 2017;6, e20674.","journal-title":"Addressing the ethical issues raised by synthetic human entities with embryo-like features. elife."},{"issue":"7602","key":"735_CR12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature17948","volume":"533","author":"A Deglincerti","year":"2016","unstructured":"Deglincerti A, Croft GF, Pietila LN, Zernicka-Goetz M, Siggia ED, Brivanlou AH. Self-organization of the in vitro attached human embryo. Nature. 2016;533(7602):251\u20134.","journal-title":"Nature"},{"key":"735_CR13","doi-asserted-by":"crossref","unstructured":"Shahbazi MN, Jedrusik A, Vuoristo S, Recher G, Hupalowska A, Bolton V, et al. Self-organization of the human embryo in the absence of maternal tissues. Nature. 2016;(6):700\u20138.","DOI":"10.1038\/ncb3347"},{"issue":"2","key":"735_CR14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/humrep\/deg072","volume":"18","author":"J Carver","year":"2003","unstructured":"Carver J, Martin K, Spyropoulou I, Barlow D, Sargent I, Mardon H. An in\u2010vitro model for stromal invasion during implantation of the human blastocyst. Hum Reprod. 2003;18(2):283\u201390.","journal-title":"Hum Reprod"},{"key":"735_CR15","unstructured":"Article 28. Regulation (EC) No 1394\/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001\/83\/EC and Regulation (EC) No 726\/2004."},{"key":"735_CR16","unstructured":"European Commission: Regulation (EC) No. 1394\/2007 on Advanced Therapy Medicinal Products. Summary of the response to the public consultation 2013."},{"key":"735_CR17","unstructured":"Hourd P, Chandra A, Medcalf N, Williams DJ. Regulatory challenges for the manufacture and scale-out of autologous cell therapies. In: StemBook (Internet). Harvard Stem Cell Institute, MA, USA (2008)."},{"issue":"18","key":"735_CR18","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1002\/cncr.27397","volume":"118","author":"RD Pentz","year":"2012","unstructured":"Pentz RD, White M, Harvey RD, Farmer ZL, Liu Y, Lewis C, Khuri FR. Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Cancer. 2012;118(18):4571\u20138.","journal-title":"Cancer"},{"issue":"S1","key":"735_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/scd.2014.0332","volume":"23","author":"M Munsie","year":"2014","unstructured":"Munsie M, Pera M. Regulatory loophole enables unproven autologous cell therapies to thrive in Australia. Stem Cells Dev. 2014;23(S1):34\u20138.","journal-title":"Stem Cells Dev"},{"key":"735_CR20","unstructured":"Therapeutic Goods Administration. Therapeutic Goods (Excluded Goods) Order No. 1. 2011; qii."},{"key":"735_CR21","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Guideline on compassionate use of medicinal products, pursuant to article 83 of regulation (EC) No 726\/2004. 2007; 2-3."},{"key":"735_CR22","unstructured":"Durisotto vs Italy. Application no. 62804\/13. European Court of Human Rights (HUDOC). 2014."},{"issue":"S1","key":"735_CR23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/scd.2013.0352","volume":"22","author":"A Blasimme","year":"2013","unstructured":"Blasimme A, Rial-Sebbag E. Regulation of cell-based therapies in Europe: current challenges and emerging issues. Stem Cells Dev. 2013;22(S1):14\u20139.","journal-title":"Stem Cells Dev"},{"issue":"S1","key":"735_CR24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/scd.2014.0361","volume":"23","author":"E Rial-Sebbag","year":"2014","unstructured":"Rial-Sebbag E, Blasimme A. The European Court of Human Rights\u2019 ruling on unproven stem cell therapies: a missed opportunity? Stem Cells Dev. 2014;23(S1):39\u201343.","journal-title":"Stem Cells Dev"},{"key":"735_CR25","unstructured":"Ministry of Health. Decree of medicinal use for gene therapy and for somatic cell therapy outside of clinical trials and transitional rules for the production of these medicines. December 5th 2006. Official Gazzette. 2007"},{"key":"735_CR26","doi-asserted-by":"crossref","unstructured":"MacGregor C, Petersen A, & Munsie M. Stem cell tourism: Selling hope through unproven stem cell treatments-lessons from the X-Cell Center controversy. Euro Stem Cell. 2015. http:\/\/www.eurostemcell.org\/commentanalysis\/stem-cell-tourism-selling-hope-through-unproven-stem-cell-treatments-lessons-x-cell- . Accessed 3 Jan 2017.","DOI":"10.1057\/978-1-137-47043-0_1"},{"key":"735_CR27","unstructured":"Abbott A. Notorious stem cell therapy centre closes in Germany. Nature News Blog. 2011. http:\/\/blogs.nature.com\/news\/2011\/05\/notorious_stem_cell_therapy_ce_1.html . Accessed 11 Dec 2017."},{"issue":"4","key":"735_CR28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/scrt474","volume":"5","author":"NM King","year":"2014","unstructured":"King NM, Perrin J. Ethical issues in stem cell research and therapy. Stem Cell Res Ther. 2014;5(4):85.","journal-title":"Stem Cell Res Ther"},{"issue":"5391","key":"735_CR29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145\u20137.","journal-title":"Science"},{"issue":"2","key":"735_CR30","first-page":"46","volume":"19","author":"A McCook","year":"2005","unstructured":"McCook A. Missouri stem-cell ban possible. The Scientist. 2005;19(2):46\u20137.","journal-title":"The Scientist"},{"key":"735_CR31","unstructured":"Danforth JC. Choose life: Support stem cell research. St. Louis Post Dispatch. May 5, 2004. Page B007. https:\/\/stltoday.newspapers.com\/image\/152147446\/?terms=J.+Danforth+Choose+life:+Support+stem+cell+research ."},{"key":"735_CR32","first-page":"138","volume":"103","author":"JC Bobrow","year":"2005","unstructured":"Bobrow JC. The ethics and politics of stem cell research. Trans Am Ophthalmol Soc. 2005;103:138.","journal-title":"Trans Am Ophthalmol Soc."},{"key":"735_CR33","unstructured":"Prohibition of Human Cloning Act (2002). Act No. 144."},{"issue":"3","key":"735_CR34","first-page":"101","volume":"82","author":"V Murugan","year":"2009","unstructured":"Murugan V. Embryonic stem cell research: a decade of debate from Bush to Obama. Yale J Biol Med. 2009;82(3):101\u20133.","journal-title":"Yale J Biol Med"},{"issue":"10","key":"735_CR35","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1172\/JCI200423549","volume":"114","author":"GD Fischbach","year":"2004","unstructured":"Fischbach GD, Fischbach RL. Stem cells: science, policy, and ethics. J Clin Invest. 2004;114(10):1364\u201370.","journal-title":"J Clin Invest"},{"key":"735_CR36","unstructured":"Obama B. \u2018Removing barriers to responsible scientific research involving human stem cells. Excecutive Order, 13505. 2009."},{"key":"735_CR37","unstructured":"Section 509 (a) of the Omnibus Appropriation Act (2009). H.R 1105 - 111th Congress."},{"key":"735_CR38","unstructured":"U.S. District Court for the District of Columbia, Sherley vs. Sebelius (2010)."},{"issue":"3","key":"735_CR39","volume":"6","author":"J Luo","year":"2011","unstructured":"Luo J, Flynn JM, Solnick RE, Ecklund EH, Matthews KR. International stem cell collaboration: how disparate policies between the United States and the United Kingdom impact research. PLoS one. 2011;6(3), e17684.","journal-title":"PLoS one"},{"issue":"9624","key":"735_CR40","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Blanc Le","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Dini G. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371(9624):1579\u201386.","journal-title":"Lancet"},{"issue":"9419","key":"735_CR41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Blanc Le","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, G\u00f6therstr\u00f6m C, Hassan M, Uzunel M, Ringd\u00e9n O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363(9419):1439\u201341.","journal-title":"Lancet"},{"issue":"3","key":"735_CR42","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2008.11.041","volume":"136","author":"MA Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez MA. Gonzalez\u2013Rey E, Rico L, B\u00fcscher D, Delgado M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology. 2009;136(3):978\u201389.","journal-title":"Gastroenterology"},{"issue":"4","key":"735_CR43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1398-9995.2010.02509.x","volume":"66","author":"H Kavanagh","year":"2011","unstructured":"Kavanagh H, Mahon BP. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy. 2011;66(4):523\u201331.","journal-title":"Allergy"},{"issue":"5","key":"735_CR44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/1352458509104590","volume":"15","author":"J Liang","year":"2009","unstructured":"Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler J. 2009;15(5):644\u20136.","journal-title":"Mult Scler J"},{"issue":"4","key":"735_CR45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-3083.2010.02378.x","volume":"71","author":"M Sioud","year":"2010","unstructured":"Sioud M, Mobergslien A, Boudabous A, Fl\u00f8isand Y. Evidence for the involvement of galectin\u20103 in mesenchymal stem cell suppression of allogeneic T\u2010cell proliferation. Scand J Immunol. 2010;71(4):267\u201374.","journal-title":"Scand J Immunol"},{"issue":"4","key":"735_CR46","doi-asserted-by":"crossref","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS One. 2010;5(4):e10088.","journal-title":"PLoS One"},{"issue":"1","key":"735_CR47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/stemcells.2007-0454","volume":"26","author":"F Liotta","year":"2008","unstructured":"Liotta F, Angeli R, Cosmi L, Fili L, Manuelli C, Frosali F, Santarlasci V. Toll\u2010like receptors 3 and 4 are expressed by human bone marrow\u2010derived mesenchymal stem cells and can inhibit their T\u2010cell modulatory activity by impairing Notch signaling. Stem Cells. 2008;26(1):279\u201389.","journal-title":"Stem Cells"},{"issue":"8","key":"735_CR48","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1089\/ten.2006.12.2263","volume":"12","author":"P Batten","year":"2006","unstructured":"Batten P, Sarathchandra P, Antoniw JW, Tay SS, Lowdell MW, Taylor PM, Yacoub MH. Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng. 2006;12(8):2263\u201373.","journal-title":"Tissue Eng"},{"issue":"12","key":"735_CR49","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel R, Zibert A, Laryea M, G\u00f6bel U, D\u00e4ubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase\u2013mediated tryptophan degradation. Blood. 2004;103(12):4619\u201321.","journal-title":"Blood"},{"issue":"2","key":"735_CR50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Shi Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2):141\u201350.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"735_CR51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","volume":"30","author":"A Bartholomew","year":"2002","unstructured":"Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Moseley A. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30(1):42\u20138.","journal-title":"Exp Hematol"},{"key":"735_CR52","unstructured":"Yu J, Thomson J. Embryonic stem cells. In: Stem cell information. Bethesda, MD: National Institutes of Health (NIH); U.S. Department of Health and Human Services; 2010."},{"issue":"9","key":"735_CR53","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.yexcr.2008.03.006","volume":"314","author":"VD Roobrouck","year":"2008","unstructured":"Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res. 2008;314(9):1937\u201344.","journal-title":"Exp Cell Res"},{"key":"735_CR54","doi-asserted-by":"crossref","unstructured":"Schrepfer S, Deuse T, Reichenspurner H, Fischbein M P, Robbins RC, & Pelletier MP. Stem cell transplantation: the lung barrier. Transpl Proc. 2007;39:573\u20136).","DOI":"10.1016\/j.transproceed.2006.12.019"},{"key":"735_CR55","doi-asserted-by":"crossref","unstructured":"Lee KO, Gan SU, Calne RY. Stem cell therapy for diabetes. Indian J Endocrinol Metab. 2012;16 Suppl 2:S227.","DOI":"10.4103\/2230-8210.104045"},{"issue":"7313","key":"735_CR56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","volume":"467","author":"K Kim","year":"2010","unstructured":"Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Yabuuchi A. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467(7313):285\u201390.","journal-title":"Nature"},{"issue":"9","key":"735_CR57","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.0910012107","volume":"107","author":"BY Hu","year":"2010","unstructured":"Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, Zhang SC. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A. 2010;107(9):4335\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7295","key":"735_CR58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature09017","volume":"465","author":"M Stadtfeld","year":"2010","unstructured":"Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, Natesan S, Hochedlinger K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature. 2010;465(7295):175\u201381.","journal-title":"Nature"},{"issue":"5644","key":"735_CR59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch PA, Sorensen R. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302(5644):415\u20139.","journal-title":"Science"},{"issue":"1","key":"735_CR60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.stem.2010.12.003","volume":"8","author":"LC Laurent","year":"2011","unstructured":"Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Ku S. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell. 2011;8(1):106\u201318.","journal-title":"Cell Stem Cell"},{"issue":"7313","key":"735_CR61","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature09328","volume":"467","author":"M Cavazzana-Calvo","year":"2010","unstructured":"Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Cavallesco R. Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia. Nature. 2010;467(7313):318\u201322.","journal-title":"Nature"},{"issue":"1","key":"735_CR62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nbt1374","volume":"26","author":"M Nakagawa","year":"2008","unstructured":"Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26(1):101\u20136.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"735_CR63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrg2937","volume":"12","author":"F Gonz\u00e1lez","year":"2011","unstructured":"Gonz\u00e1lez F, Bou\u00e9 S, Belmonte JCI. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet. 2011;12(4):231\u201342.","journal-title":"Nat Rev Genet"},{"issue":"10","key":"735_CR64","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/jnr.22054","volume":"87","author":"SU Kim","year":"2009","unstructured":"Kim SU, De Vellis J. Stem cell\u2010based cell therapy in neurological diseases: a review. J Neurosci Res. 2009;87(10):2183\u2013200.","journal-title":"J Neurosci Res"},{"issue":"6","key":"735_CR65","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.stem.2012.05.010","volume":"10","author":"GQ Daley","year":"2012","unstructured":"Daley GQ. The promise and perils of stem cell therapeutics. Cell Stem Cell. 2012;10(6):740\u20139.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"735_CR66","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1755-5949.2011.00239.x","volume":"18","author":"Z Feng","year":"2012","unstructured":"Feng Z, Gao F. Stem cell challenges in the treatment of neurodegenerative disease. CNS Neurosci Ther. 2012;18(2):142\u20138.","journal-title":"CNS Neurosci Ther"},{"issue":"13","key":"735_CR67","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa061267","volume":"355","author":"AJ Shapiro","year":"2006","unstructured":"Shapiro AJ, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Cagliero E. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355(13):1318\u201330.","journal-title":"N Engl J Med"},{"issue":"2","key":"735_CR68","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca FW, Millman JR, G\u00fcrtler M, Segel M, Van Dervort A, Ryu JH, Melton DA. Generation of functional human pancreatic \u03b2 cells in vitro. Cell. 2014;159(2):428\u201339.","journal-title":"Cell"},{"issue":"11-12","key":"735_CR69","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3727\/096368910X564085","volume":"20","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, Gan SU, Lin G, Lim YT, Masilamani J, Mustafa FB, Calne R. Characterization of human umbilical cord lining-derived epithelial cells and transplantation potential. Cell Transplant. 2011;20(11-12):1827\u201341.","journal-title":"Cell Transplant"},{"issue":"3","key":"735_CR70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrendo.2009.276","volume":"6","author":"RY Calne","year":"2010","unstructured":"Calne RY, Gan SU, Lee KO. Stem cell and gene therapies for diabetes mellitus. Nat Rev Endocrinol. 2010;6(3):173\u20137.","journal-title":"Nat Rev Endocrinol"},{"issue":"9817","key":"735_CR71","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","volume":"379","author":"SD Schwartz","year":"2012","unstructured":"Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379(9817):713\u201320.","journal-title":"Lancet"},{"issue":"376","key":"735_CR72","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJMoa1609583","volume":"2017","author":"AE Kuriyan","year":"2017","unstructured":"Kuriyan AE, Albini TA, Townsend JH, Rodriguez M, Pandya HK, Leonard RE, Goldberg JL. Vision loss after intravitreal injection of autologous \u201cstem cells\u201d for AMD. N Engl J Med. 2017;2017(376):1047\u201353.","journal-title":"N Engl J Med"},{"issue":"30","key":"735_CR73","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","volume":"36","author":"P Menasch\u00e9","year":"2015","unstructured":"Menasch\u00e9 P, Vanneaux V, Hag\u00e8ge A, Bel A, Cholley B, Cacciapuoti I, Trouvin JH. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur Heart J. 2015;36(30):2011\u20137.","journal-title":"Eur Heart J"},{"issue":"7500","key":"735_CR74","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13309","volume":"509","author":"JH Berlo Van","year":"2014","unstructured":"Van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin SCJ, Molkentin JD. C-kit\u2009+\u2009cells minimally contribute cardiomyocytes to the heart. Nature. 2014;509(7500):337\u201341.","journal-title":"Nature"},{"issue":"9806","key":"735_CR75","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","volume":"378","author":"R Bolli","year":"2011","unstructured":"Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Sanada F. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378(9806):1847\u201357.","journal-title":"Lancet"},{"issue":"2","key":"735_CR76","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4252\/wjsc.v6.i2.120","volume":"6","author":"VR Dasari","year":"2014","unstructured":"Dasari VR, Veeravalli KK, Dinh DH. Mesenchymal stem cells in the treatment of spinal cord injuries: a review. World J Stem Cells. 2014;6(2):120.","journal-title":"World J Stem Cells"},{"issue":"8","key":"735_CR77","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/scd.2010.0466","volume":"20","author":"JC Ra","year":"2011","unstructured":"Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kwon E. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011;20(8):1297\u2013308.","journal-title":"Stem Cells Dev"},{"issue":"4","key":"735_CR78","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3727\/096368915X687796","volume":"24","author":"D Jarocha","year":"2015","unstructured":"Jarocha D, Milczarek O, Wedrychowicz A, Kwiatkowski S, Majka M. Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury. Cell Transplant. 2015;24(4):661\u201372.","journal-title":"Cell Transplant"},{"key":"735_CR79","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.110.2865.543","volume":"110","author":"L Pauling","year":"1949","unstructured":"Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia. Science. 1949;110:543\u20138.","journal-title":"Science."},{"issue":"1","key":"735_CR80","first-page":"27","volume":"16","author":"WC Mentzer","year":"1994","unstructured":"Mentzer WC, Heller S, Pearle PR, Hackney E, Vichinsky E. Availability of related donors for bone marrow transplantation in sickle cell anemia. J Pediatr Hematol Oncol. 1994;16(1):27\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"735_CR81","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2040620713483063","volume":"4","author":"S Shenoy","year":"2013","unstructured":"Shenoy S. Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions. Therapeutic Adv Hematol. 2013;4(5):335\u201344.","journal-title":"Therapeutic Adv Hematol"},{"issue":"20","key":"735_CR82","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.2010.651","volume":"303","author":"I Boutron","year":"2010","unstructured":"Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303(20):2058\u201364.","journal-title":"JAMA"},{"key":"735_CR83","doi-asserted-by":"crossref","first-page":"g2688","DOI":"10.1136\/bmj.g2688","volume":"348","author":"AN Nowbar","year":"2014","unstructured":"Nowbar AN, Mielewczik M, Karavassilis M, Dehbi HM, Shun-Shin MJ, Jones S, Francis DP. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ. 2014;348:g2688.","journal-title":"BMJ."},{"issue":"7485","key":"735_CR84","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nature12968","volume":"505","author":"H Obokata","year":"2014","unstructured":"Obokata H, Wakayama T, Sasai Y, Kojima K, Vacanti MP, Niwa H, Vacanti CA. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature. 2014;505(7485):641\u20137.","journal-title":"Nature"},{"key":"735_CR85","doi-asserted-by":"crossref","unstructured":"Obokata H, Wakayama T, Sasai Y, Kojima K, Vacanti MP, Niwa H, et al. Retraction: Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature. 2014;505.7485:641\u20137.","DOI":"10.1038\/nature12968"},{"key":"735_CR86","unstructured":"Edgerton D. The \u2018Haldane Principle\u2019 and other invented traditions in science policy. History and Policy. 2009. http:\/\/www.historyandpolicy.org\/policy-papers\/papers\/the-haldane-principle-and-other-invented-traditions-in-science-policy ."},{"key":"735_CR87","unstructured":"Poulos J. Freedom of Information Request to the Department of Health under the Freedom of Information Act (2000). FOI-1058082. Request made 4th November 2016."},{"issue":"3","key":"735_CR88","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/mt.2012.13","volume":"20","author":"R Maciulaitis","year":"2012","unstructured":"Maciulaitis R, D'apote L, Buchanan A, Pioppo L, Schneider CK. Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive. Mol Ther. 2012;20(3):479\u201382.","journal-title":"Mol Ther"},{"issue":"1","key":"735_CR89","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cne.10266","volume":"449","author":"MH Tuszynski","year":"2002","unstructured":"Tuszynski MH, Grill R, Jones LL, McKay HM, Blesch A. Spontaneous and augmented growth of axons in the primate spinal cord: Effects of local injury and nerve growth factor\u2010secreting cell grafts. J Comp Neurol. 2002;449(1):88\u2013101.","journal-title":"J Comp Neurol"},{"issue":"5","key":"735_CR90","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","volume":"11","author":"MH Tuszynski","year":"2005","unstructured":"Tuszynski MH, Thal L, Pay M, Salmon DP, Bakay R, Patel P, Potkin SG. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005;11(5):551\u20135.","journal-title":"Nat Med"},{"key":"735_CR91","doi-asserted-by":"crossref","unstructured":"Lee DH, et al. Stem cell-based cell therapy for spinal cord injury. Cell Transplant 16. 2007; 355\u2013364","DOI":"10.3727\/000000007783464885"},{"issue":"50","key":"735_CR92","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1523\/JNEUROSCI.3364-09.2009","volume":"29","author":"O Einstein","year":"2009","unstructured":"Einstein O, Friedman-Levi Y, Grigoriadis N, Ben-Hur T. Transplanted neural precursors enhance host brain-derived myelin regeneration. J Neurosci. 2009;29(50):15694\u2013702.","journal-title":"J Neurosci"},{"issue":"1","key":"735_CR93","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nbd.2004.01.016","volume":"16","author":"JK Ryu","year":"2004","unstructured":"Ryu JK, Kim J, Cho SJ, Hatori K, Nagai A, Choi HB, Kim SU. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. Neurobiol Dis. 2004;16(1):68\u201377.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"735_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1789.2007.00858.x","volume":"28","author":"M Kim","year":"2008","unstructured":"Kim M, Lee ST, Chu K, Kim SU. Stem cell\u2010based cell therapy for Huntington disease: a review. Neuropathology. 2008;28(1):1\u20139.","journal-title":"Neuropathology"},{"issue":"2","key":"735_CR95","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.reprotox.2003.10.015","volume":"18","author":"A Seiler","year":"2004","unstructured":"Seiler A, Visan A, Buesen R, Genschow E, Spielmann H. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod Toxicol. 2004;18(2):231\u201340.","journal-title":"Reprod Toxicol"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-017-0735-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T17:15:01Z","timestamp":1660238101000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-017-0735-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1186\/s13287-017-0735-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,2]]},"article-number":"1"}}